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Sestrin2, a regulator of
thermogenesis and mitohormesis
in brown adipose tissue
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Sestrin2 is a stress-inducible protein that functions as an antioxidant and inhibitor of
mTOR complex 1. In a recent study, we found that Sestrin2 overexpression in brown
adipocytes interfered with normal metabolism by reducing mitochondrial respiration
through the suppression of uncoupling protein 1 (UCP1) expression. Themetabolic effects
of Sestrin2 in brown adipocytes were dependent on its antioxidant activity, and chem-
ical antioxidants produced similar effects in inhibiting UCP1-dependent thermogenesis.
These observations suggest that low levels of reactive oxygen species (ROS) in brown
adipocytes can actually be beneficial and necessary for proper metabolic homeostasis. In
addition, considering that Sestrins are ROS inducible and perform ROS detoxifying as well
as other metabolism-controlling functions, they are potential regulators of mitohormesis.
This is a concept in which overall beneficial effects result from low-level oxidative stress
stimuli, such as the ones induced by caloric restriction or physical exercise. In this
perspective, we incorporate our recent insight obtained from the Sestrin2 study toward
a better understanding of the relationship between ROS, Sestrin2, and mitochondrial
metabolism in the context of brown adipocyte physiology.
Keywords: Sestrin2, brown adipose tissue, mitochondria metabolism, thermogenesis, reactive oxygen species,
antioxidants, mitohormesis, aging
Introduction: Sestrins
Sestrins are a group of stress-inducible proteins, which are highly conserved across species and
have two distinct biologically active functions (1). First, they function as an antioxidant that
suppresses reactive oxygen species (ROS) accumulation (2, 3) through a poorly characterized
biochemical mechanism (4), which may involve regulation of antioxidant transcription factors
(5). Independently of this redox function, Sestrins also act as feedback inhibitors of mecha-
nistic target of rapamycin complex 1 (mTORC1) through activation of AMP-activated protein
kinase (AMPK) (6, 7) or through inhibition of Rag GTPases (8–11). Through these functions,
Sestrins have been shown to attenuate multiple age- and obesity-associated metabolic patholo-
gies, such as fat accumulation, glucose intolerance, insulin resistance, mitochondrial dysfunc-
tion, muscle degeneration, and cardiac malfunction (5–7, 12–15). Because the expression of
Sestrins is induced upon a variety of environmental stresses, such as DNA damage, oxida-
tive stress, and hypoxia (2), Sestrins are considered a mechanistic link between stress and
aging (16).
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ROS as Signaling Molecules
Reactive oxygen species are a group of free oxygen radicals and
reactive non-radicals, such as superoxide
 
O 2

, hydroxyl radical
(OH), nitric oxide (NO), and hydrogen peroxide (H2O2) (17–
19). In mammalian cells, ROS can be generated from various
sources, such as mitochondria, peroxisomes, and ROS-producing
cytosolic enzymes, such as NADPH oxidases (20–23). Under nor-
mal physiological conditions, the intracellular levels of ROS are
homeostatically controlled. However, aberrantly increased ROS
levels can damage intracellular organelles and critical macro-
molecules, such as proteins, DNA, and lipids. The ROS-induced
oxidative damage can contribute to the development of numer-
ous pathological disorders, such as cardiovascular disease, neu-
rodegenerative diseases, mitochondrial disease, obesity, diabetes,
cancer, and aging (24–30).
Although ROS were initially considered to be undesired
byproducts of metabolism (31), a modernized view of ROS has
emerged; ROS are now considered to be important signaling
molecules (32–35). ROS can control diverse signaling pathways,
including MAPK/ERK1/2 pathway (36, 37), PI3K/Akt pathway
(38, 39), IKK/NF-kB pathway (40–42), and p38 MAPK pathway
(43, 44), which are critically involved in cell growth, differenti-
ation, metabolism, and inflammation. Through these pathways,
ROS contribute to the maintenance of physiological homeostasis
in cells and tissues (45–49). These new findings support the con-
cept of mitohormesis, which explains how physiological ROS can
be beneficial to the cells and organism; ROS serve as sub-lethal
stressors that act as signaling molecules to induce endogenous
defense mechanisms, which ultimately improve mitochondrial
metabolism and promote stress resistance, metabolic health, and
longevity (50–52).
Role of ROS in BAT Metabolism
BAT is the organ mainly responsible for non-shivering thermoge-
nesis, which ismediated by uncoupling protein 1 (UCP1) (53–55).
UCP1 is the key protein for thermogenesis, which is specifically
induced in BAT upon exposure to cold temperature. Low tem-
peratures activate p38MAPK by stimulating sympathetic neurons
and inducing cAMP accumulation in BAT (56–58). Activated
p38 MAPK subsequently activates several transcription factors,
such as ATF-2 and PGC-1α, which induces UCP1 expression
in BAT (58, 59). By translocating into the mitochondrial inner
membrane and dissipating the proton gradient, UCP1 uncouples
mitochondrial respiration from ATP synthesis and generates heat
(53, 60).UCP1-dependent thermogenesis in BAT increases energy
expenditure reduces body fat and improvesmetabolic homeostasis
(60, 61).
Chronic accumulation of ROS produced by dysfunctional
mitochondria may deteriorate the BAT metabolism (62, 63),
which can be one of the mechanisms of how aging and obesity
interferes with BATmetabolism (64–66). In this respect, suppress-
ing excessive ROS might be key to reinforcing BAT metabolism
against aging. Chemical antioxidants, artificial or naturally occur-
ring substances, serve to scavenge ROS, many of which are
byproducts of cellular metabolism, which when in excess can
cause oxidative damage and promote disease development and
aging (26, 32). Most cells utilize various antioxidant enzymes,
such as catalases, superoxide dismutases, glutathione peroxidases,
peroxiredoxins, and Sestrins, which serve to reduce the negative
consequences of ROS accumulation (3, 33, 67). We have recently
investigated the role of ROS in BAT metabolism through the use
of chemical antioxidants, such as butylated hydroxyanisole (BHA)
and N-acetylcysteine (NAC), as well as forced overexpression of
Sestrin2 (68).
Surprisingly, our recent results indicated that physiological lev-
els of ROS could also play a critical role in thermogenic processes
(68). BHA and NAC, as well as Sestrin2 overexpression, resulted
in a strong reduction of UCP1 expression in BAT. Subsequent
in vitro and in vivo studies showed that physiological ROS in BAT
potentiate cAMP-induced p38 MAPK activation, which medi-
ates cold-induced UCP1 expression. Correspondingly, Sestrin2-
overexpressing mice were unable to upregulate UCP1 or generate
heat in response to cold exposure. These results demonstrate that
ROS are critical for proper BATmetabolism. Therefore, prolonged
antioxidant treatment may interfere with thermogenesis and pos-
sibly other ROS-dependent physiological processes. This idea is
consistent with recent reports where administered antioxidants
had neutral or negative effects on health and life span in animals
and humans (69, 70).
Caloric Restriction and Physical Exercise
as Potential Inducers of ROS and
Mitohormesis
Caloric restriction, being defined as a reduction in ad libi-
tum calorie uptake, has been shown to extend life span in
a variety of organisms (71). Notably, emerging evidence indi-
cates that caloric restriction is capable of increasing mitochon-
drial metabolism, such as oxidative respiration, in yeast (72),
Caenorhabditis elegans (73) and Drosophila (74, 75). Increased
production of ROS as a consequence of increased mitochondrial
respiration has been suggested to be a critical regulator of life
span during caloric restriction (73, 76–79). Caloric restriction-
induced ROS can stimulate antioxidant defense mechanisms,
such as radical-scavenging enzymes, that mediate various mito-
hormetic responses (5, 73, 80–82). Carbohydrate-deficient diets
also increase oxidative metabolism, subsequently resulting in
enhanced ROS defense (83). Therefore, these recent studies sug-
gest that caloric restriction increases longevity at least partially
by inducing oxidative metabolism and a mitohormetic defense
system.
Physical exercise undoubtedly provides positive effects on
diverse diseases, such as obesity, type 2 diabetes, cardiovascular
disease, cancer, and general aging (84–88). Similar to caloric
restriction, exercise is capable of increasingmitochondrial biogen-
esis, oxidative metabolism, and mitochondrial ROS production
(89–92). Many studies propose that exercise-induced ROS con-
tributes to mitohormesis, which increases health span and mean
life span (93–97). Because co-treatment with antioxidants pre-
vented the beneficial mitohormetic response of physical exercise
(85, 98), physiological ROS produced by exercise was considered
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FIGURE 1 | Current model of the mitohormetic relationship between
ROS, Sestrin2, and mitochondrial thermogenesis. Under conditions of
excessive or decreased ROS, BAT thermogenesis is impaired. However, a
physiological level of ROS is able to maintain proper BAT metabolism. (A) In
cases where antioxidant activity is low, such as in the absence of Sestrin2, ROS
levels are upregulated. Excessive ROS may directly impair mitochondrial
homeostasis by direct damage to the organelle. In addition, Sestrin2 is critical
for mitochondrial biogenesis. Therefore, in the absence of Sestrin2, BAT
mitochondrial content is decreased as well as its thermogenic capacity.
(B) When Sestrin2 is physiologically expressed, an adequate level of ROS is
produced to ensure proper p38 MAPK activation and UCP1 expression.
Physiological Sestrin2 expression promotes mitochondrial biogenesis, and the
mitohormetic mechanism conferred by Sestrin2 is necessary to maintain proper
BAT metabolism such as thermogenesis. (C) When Sestrin2 is overexpressed,
ROS are dramatically suppressed. Because ROS are critical for UCP1
expression in BAT, Sestrin2 overexpression decreases UCP1 expression.
Although mitochondrial biogenesis is enhanced by Sestrin2 overexpression,
decreased UCP1 expression prohibits proper thermogenesis in BAT.
critical for the benefits of exercise. Therefore, both caloric restric-
tion and exercise seem to utilize physiological ROS induction as
a means to induce antioxidant defense and promote the life and
health span of an organism.
Sestrins as Potential Regulators of
Mitohormesis
Sestrins have been identified as important regulators of age-
and obesity-associated pathologies in diverse tissues including
liver, adipose, and muscle (5–7, 12–15, 68). Sestrins are thought
to attenuate tissue aging through their dual biological activities
in reducing ROS and inhibiting mTORC1 (1, 2, 16). Excessive
accumulation of ROS and chronic activation of mTORC1 signal-
ing are well-known promoters of tissue aging. Considering that
Sestrins are transcriptionally activated upon oxidative stress, it
is highly likely that Sestrins may be regulators of mitohormesis.
For example, upon a non-toxic level of ROS stimuli, Sestrins
may be induced to perform antioxidant andmTORC1-suppressive
functions to defend against oxidative damage and attenuate tis-
sue aging.
It should also be noted that, although critical for attenuating
tissue aging, the loss of Sestrins per sedoes not substantially reduce
life span ofDrosophila (1) orC. elegans (15). This could be because
there are unknown compensatory mechanisms instigated by the
loss of Sestrins, which are capable of maintaining life span, but are
not sufficient to restore health span. However, Sestrin-deficient C.
elegans is hypersensitive to oxidative stress (15), suggesting that
Sestrin is indeed critical for the stress adaptation of an organism.
It has been shown in the same organism that low levels of oxidative
stress (conferred by a chemical that induces mitochondrial ROS)
can increase the life span ofC. elegans (99, 100). Caloric restriction
in C. elegans extends life span partially by inducing mitochondrial
production of ROS (73). Therefore, it would be very interesting to
investigate if Sestrins are indeed regulators of the mitohormetic
effect in these aging models.
Role of Sestrin2 in BAT Metabolism
Although the beneficial role of Sestrins in attenuating tissue aging
and obesity-associated metabolic pathologies has been clear in
several tissues, such as liver and skeletal/cardiac muscle (6, 7,
12, 13), the role of Sestrin2 in BAT metabolism seems to be
more complicated. As discussed above, Sestrin2 overexpression in
BAT interferes with proper UCP1 expression and mitochondrial
uncoupling (68). Even though Sestrin2 overexpression activated
AMPK and subsequently promoted mitochondrial biogenesis,
these beneficial effects were nullified by the drastic effect of UCP1
loss. As a result, the Sestrin2-overexpressing mice were defective
in BAT thermogenesis and exhibited increased fat accumula-
tion (68).
Interestingly, loss of Sestrin2 also interfered with proper BAT
metabolism. Although UCP1 expression was relatively increased
in BAT of Sestrin2-deficient mice, the whitening of BAT due to
fat accumulation is markedly increased upon Sestrin2 deficiency
(68). Analysis of mRNA markers for mitochondrial biogenesis
and quantification of mitochondrial DNA suggests that BAT from
Sestrin2-deficient mice exhibited decreased mitochondrial con-
tents (68). This could be because Sestrin2 plays a critical role
in producing sufficient amounts of mitochondria in BAT, which
would be necessary for proper energy dissipation and homeostatic
BATmetabolism. Sestrin2may promotemitochondrial biogenesis
through activation of AMPK (7, 12, 101, 102) and subsequent
upregulation of PGC-1α activity (103, 104). Therefore, although
overexpression of Sestrin2 can interfere with the physiological
level of ROS necessary for thermogenesis control, endogenous
Sestrin2 still plays a critical role in maintaining mitochondrial
homeostasis.
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Conclusion
Upon diverse environmental stresses including oxidative stress,
Sestrin-family proteins are transcriptionally upregulated to reduce
pathogenic levels of ROS and suppress chronic activation of
mTORC1 signaling. As chronic ROS accumulation and prolonged
mTORC1 activation are both detrimental for metabolic home-
ostasis, Sestrins are potential regulators of mitohormesis, which
is a beneficial metabolic effect of low-level ROS production.
Sestrins may also play a critical metabolism-controlling role in
BAT. However, because ROS are also critical for UCP1 expression
and subsequent mitochondrial uncoupling, artificial overexpres-
sion of Sestrin2 and subsequent elimination of ROS interfered
with non-shivering thermogenesis, which is one of the most
critical physiological functions of BAT. Therefore, it is highly
likely that ROS levels, Sestrin2 expression, and mitochondrial
metabolism are connected to each other through a complicated
and finely coordinated network, and a delicate balance between
these components seems to be critical for proper BAT homeosta-
sis (Figure 1).
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